생물학적 연령 및 장수 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global biological age and longevity diagnostics market size is expected to reach USD 11.09 Billion in 2034 from USD 3.38 Billion in 2025, growing at a CAGR of 14.11% during 2026-2034.This market is emerging as researchers and healthcare providers explore methods to assess biological ageing and understand factors associated with long-term health. Biological age and longevity diagnostics use different biomarkers, molecular measurements, and analytical models to estimate aspects of an individual's biological condition beyond chronological age. These approaches may involve epigenetic markers, blood-based measurements, metabolic indicators, and other biological data. Growing interest in preventive healthcare, healthy ageing, and personalized wellness is encouraging research and product development. Advances in molecular biology and computational analysis are also helping scientists investigate the relationship between biological changes and age-related health outcomes.

The growth of this market is driven by increasing interest in preventive medicine, expanding longevity research, and improvements in biomarker analysis. Research institutions and biotechnology companies are developing tests intended to assess biological ageing patterns and investigate associations with lifestyle, disease risk, and health outcomes. Artificial intelligence and advanced statistical methods can help analyze complex biological datasets and identify patterns that may be relevant to ageing research. Consumer interest in personalized wellness assessments is also creating commercial opportunities. However, differences in testing methods, limited standardization, clinical validation requirements, and uncertainty about how results should guide medical decisions remain important challenges.

The future prospects of this market will depend on scientific progress, stronger clinical evidence, and the development of more reliable biological ageing assessments. Improved biomarker panels and analytical models may help researchers better understand ageing processes and evaluate changes over time. Integration with preventive healthcare programs could create opportunities if testing methods demonstrate meaningful clinical value. Pharmaceutical and biotechnology companies may also use these diagnostics in studies involving age-related diseases and therapeutic development. Future growth will depend on reproducibility, regulatory requirements, affordability, ethical data handling, and clear evidence that diagnostic results provide useful information for healthcare decisions.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Test Type

• Epigenetic Age Testing
• Telomere Length Testing
• Multi Omics Diagnostics
• Proteomic Aging Tests
• Microbiome Based Longevity Diagnostics
• Cellular Senescence Biomarker Tests
• Organ Age Assessment Tests

By Sample Type

• Blood Samples
• Saliva Samples
• Urine Samples
• Tissue Samples
• Buccal Swab Samples
• Hair Samples

By Application Type

• Preventive Healthcare
• Personalized Medicine
• Chronic Disease Risk Assessment
• Wellness And Fitness Monitoring
• Anti Aging Research

By End User

• Hospitals And Clinics
• Diagnostic Laboratories
• Research Institutes
• Longevity Clinics
• Academic Institutions
• Direct To Consumer Users
• Pharmaceutical And Biotechnology Companies

COMPANIES PROFILED

• Altos Labs, TruDiagnostic, Viome Life Sciences Inc., Function Health, Elysium Health Inc., InsideTracker Inc., Human Longevity Inc., FOXO Technologies Inc., GlycanAge Ltd., Gero PTE. Ltd., Decode Age Technologies Pvt. Ltd., MyDNAge Inc., Generation Lab, SiPhox Inc, Neko Health, Circulate Health, EpiMedTech Global

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICAL AGE AND LONGEVITY DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Epigenetic Age Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Telomere Length Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Multi Omics Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Proteomic Aging Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Microbiome Based Longevity Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Cellular Senescence Biomarker Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Organ Age Assessment Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICAL AGE AND LONGEVITY DIAGNOSTICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample Type
• 5.2. Blood Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Saliva Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urine Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tissue Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Buccal Swab Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Hair Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICAL AGE AND LONGEVITY DIAGNOSTICS MARKET: BY APPLICATION TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application Type
• 6.2. Preventive Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Chronic Disease Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Wellness And Fitness Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Anti Aging Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICAL AGE AND LONGEVITY DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Longevity Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Academic Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Direct To Consumer Users Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOLOGICAL AGE AND LONGEVITY DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Test Type
  • 8.2.2 By Sample Type
  • 8.2.3 By Application Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Test Type
  • 8.3.2 By Sample Type
  • 8.3.3 By Application Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Test Type
  • 8.4.2 By Sample Type
  • 8.4.3 By Application Type
  • 8.4.4 By End User
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Test Type
  • 8.5.2 By Sample Type
  • 8.5.3 By Application Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Test Type
  • 8.6.2 By Sample Type
  • 8.6.3 By Application Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOLOGICAL AGE AND LONGEVITY DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Altos Labs
  • 10.2.2 TruDiagnostic
  • 10.2.3 Viome Life Sciences Inc
  • 10.2.4 Function Health
  • 10.2.5 Elysium Health Inc
  • 10.2.6 InsideTracker Inc
  • 10.2.7 Human Longevity Inc
  • 10.2.8 FOXO Technologies Inc
  • 10.2.9 GlycanAge Ltd
  • 10.2.10 Gero PTE. Ltd
  • 10.2.11 Decode Age Technologies Pvt. Ltd
  • 10.2.12 MyDNAge Inc
  • 10.2.13 Generation Lab
  • 10.2.14 SiPhox Inc
  • 10.2.15 Neko Health
  • 10.2.16 Circulate Health
  • 10.2.17 EpiMedTech Global